SABS vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

SABS

32.4
AI Score
VS
JBIO Wins

JBIO

36.0
AI Score

Investment Advisor Scores

SABS

32score
Recommendation
SELL

JBIO

36score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SABS JBIO Winner
Net Income 13.27M -96.13M SABS
Operating Income -48.95M -102.36M SABS
ROE 8.8% -21.9% SABS
ROA 7.7% -20.4% SABS
Total Assets 172.81M 472.11M JBIO
Cash 10.50M 107.25M JBIO
Current Ratio 9.46 14.93 JBIO
Free Cash Flow -45.71M -67.93M SABS

Relative Price Performance (Last 90 Days)

SABS 1M: +23.7% · 3M: -16.8% JBIO 1M: +18.1% · 3M: -35.8%

Current Technical Phase

SABS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.4 · Price: $3.08

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 56

RSI (14): 56.2 · Price: $15.87

Fundamentals Snapshot

Metric SABS JBIO
Market Cap — —
Forward P/E -3.3 -6.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.6% 0.0%
Gross Margin -500.2% —
Operating Margin 0.0% 0.0%
EPS -1.35 -1.92
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, JBIO is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.